Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 37.5B | 21.3B | 16.8B | 24.0B |
Cost of revenue | 31.3B | 17.3B | 13.5B | 19.7B |
Gross profit | 6.2B | 4.0B | 3.4B | 4.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.4B | 1.6B | 1.5B | 1.5B |
Operating income | 2.4B | 999.8M | 571.0M | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 545.9M | 536.6M | 486.4M | 518.4M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 532.8M | 236.1M | 1.0B |
Tax provision | 701.6M | 162.4M | 26.5M | 297.7M |
Net income | 1.2B | 370.5M | 209.6M | 747.2M |
Basic EPS | — | 10.6 | 5.7 | 21.5 |
Diluted EPS | — | 10.6 | 5.7 | 21.4 |
Basic average shares | — | 33.8M | 33.8M | 33.7M |
Diluted average shares | — | 34.0M | 33.9M | 33.8M |
EBITDA | 3.0B | 1.7B | 1.3B | 2.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -23.5M | -11.8M | -17.1M | -23.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |